Accession PRJCA014920
Title Development of biomarkers and new therapeutic targets for hepatobiliary diseases based on omics profile
Relevance Medical
Data types metabolomics, proteomics
Organisms Homo sapiens
mixed sample
Description Use omics technology to screen specific biomarkers for liver and gallbladder diseases such as malignant tumors of the hepatobiliary system, autoimmune liver disease, non-alcoholic fatty liver, etc., for early diagnosis and treatment of hepatobiliary diseases
Sample scope Multispecies
Release date 2023-10-09
Publication
PubMed ID Article title Journal name DOI Year
37403919 Integration of Metabolomics, Lipidomics, and Proteomics Reveals the Metabolic Characterization of Nonalcoholic Steatohepatitis Journal of Proteome Research 10.1021/acs.jproteome.3c00009 2023
Grants
Agency program Grant ID Grant title
National Natural Science Foundation of China (NSFC) 32170594
Submitter Tian Xin (tianx@zzu.edu.cn)
Organization The First Affiliated Hospital of Zhengzhou University
Submission date 2023-02-13

Project Data

Resource name Description